It was reported that angiotensin-converting enzyme 2 (ACE2)-positive epithelial cells of the salivary gland are an early target of SARS-CoV-2 in rhesus macaques, and these findings suggest that oral manifestations may appear due to impediment of salivary flow in COVID-19-affected patients [17]. This evidence concerns the gene ACE2 and COVID-19.